A. P. Moore

2.1k total citations
24 papers, 1.5k citations indexed

About

A. P. Moore is a scholar working on Neurology, Genetics and Psychiatry and Mental health. According to data from OpenAlex, A. P. Moore has authored 24 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Neurology, 5 papers in Genetics and 5 papers in Psychiatry and Mental health. Recurrent topics in A. P. Moore's work include Botulinum Toxin and Related Neurological Disorders (9 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Hereditary Neurological Disorders (4 papers). A. P. Moore is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (9 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Hereditary Neurological Disorders (4 papers). A. P. Moore collaborates with scholars based in United Kingdom, Germany and Australia. A. P. Moore's co-authors include Michael J Leathley, Anil Kumar Sharma, Caroline Watkins, T L Smith, S J Smith, Sarah White, Elizabeth Ellis, Sean J. Pittock, Frank Erbguth and S. Otto and has published in prestigious journals such as Nature Communications, Blood and British Journal of Cancer.

In The Last Decade

A. P. Moore

24 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. P. Moore United Kingdom 15 1.1k 776 610 218 118 24 1.5k
Patricia S. Smith United States 15 261 0.2× 526 0.7× 238 0.4× 110 0.5× 35 0.3× 33 1.2k
S. Miller United Kingdom 18 211 0.2× 252 0.3× 128 0.2× 72 0.3× 179 1.5× 40 1.4k
Toshio Fukutake Japan 21 1.1k 1.0× 73 0.1× 102 0.2× 444 2.0× 95 0.8× 84 1.6k
S. Pandya United States 12 153 0.1× 161 0.2× 209 0.3× 242 1.1× 237 2.0× 19 1.7k
Jeanine Schierbecker United States 8 139 0.1× 158 0.2× 165 0.3× 198 0.9× 213 1.8× 9 1.5k
Prodip Bose United States 20 171 0.2× 90 0.1× 271 0.4× 122 0.6× 75 0.6× 43 895
L. Signore United States 10 125 0.1× 184 0.2× 207 0.3× 222 1.0× 261 2.2× 10 1.9k
M. Comola Italy 16 285 0.3× 97 0.1× 72 0.1× 124 0.6× 114 1.0× 50 797
B. Cioni Italy 21 296 0.3× 69 0.1× 106 0.2× 134 0.6× 127 1.1× 48 1.4k
Rita Krishnamurthi New Zealand 7 176 0.2× 151 0.2× 137 0.2× 524 2.4× 186 1.6× 13 1.8k

Countries citing papers authored by A. P. Moore

Since Specialization
Citations

This map shows the geographic impact of A. P. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. P. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. P. Moore more than expected).

Fields of papers citing papers by A. P. Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. P. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. P. Moore. The network helps show where A. P. Moore may publish in the future.

Co-authorship network of co-authors of A. P. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of A. P. Moore. A scholar is included among the top collaborators of A. P. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. P. Moore. A. P. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maiqués-Díaz, Alba, Elena Hartmann, Johannes Bloehdorn, et al.. (2022). Viral transduction of primary human lymphoma B cells reveals mechanisms of NOTCH-mediated immune escape. Nature Communications. 13(1). 6220–6220. 19 indexed citations
2.
Sathiaseelan, Vijitha, A. P. Moore, Shengjiang Tan, et al.. (2021). ZAP-70 constitutively regulates gene expression and protein synthesis in chronic lymphocytic leukemia. Blood. 137(26). 3629–3640. 16 indexed citations
3.
Park, Eugene, A. P. Moore, Antonella Santoro, et al.. (2020). Stromal cell protein kinase C-β inhibition enhances chemosensitivity in B cell malignancies and overcomes drug resistance. Science Translational Medicine. 12(526). 22 indexed citations
4.
Moore, A. P., et al.. (2020). ZAP-70 Shapes the Immune Microenvironment in B Cell Malignancies. Frontiers in Oncology. 10. 595832–595832. 20 indexed citations
5.
Wagner, Michaela, Madlen Oelsner, A. P. Moore, et al.. (2015). Integration of innate into adaptive immune responses in ZAP-70–positive chronic lymphocytic leukemia. Blood. 127(4). 436–448. 21 indexed citations
6.
Kelley, Robin Kate, Justin H. Hwang, Mark Jesus M. Magbanua, et al.. (2013). A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer. British Journal of Cancer. 109(7). 1725–1734. 33 indexed citations
7.
Pathak, Mayank, Han Thi Ngoc Nguyen, H. Kerr Graham, & A. P. Moore. (2006). Management of spasticity in adults: practical application of botulinum toxin. European Journal of Neurology. 13(s1). 42–50. 37 indexed citations
8.
Moore, A. P. & Sasi Willmott. (2004). Does a limited nurse triage service reduce junior doctor psychiatric on-call workload?. Psychiatric Bulletin. 28(10). 368–370. 1 indexed citations
9.
Pittock, Sean J., A. P. Moore, Orla Hardiman, et al.. (2003). A Double-Blind Randomised Placebo-Controlled Evaluation of Three Doses of Botulinum Toxin Type A (Dysport<sup>®</sup>) in the Treatment of Spastic Equinovarus Deformity after Stroke. Cerebrovascular Diseases. 15(4). 289–300. 157 indexed citations
10.
Moore, A. P.. (2002). Botulinum toxin A (BoNT‐A) for spasticity in adults. What is the evidence?. European Journal of Neurology. 9(s1). 42–47. 18 indexed citations
11.
Bakheit, A. M. O., et al.. (2001). A randomized, double‐blind, placebo‐controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke. European Journal of Neurology. 8(6). 559–565. 173 indexed citations
12.
Moore, A. P., et al.. (2001). ABSTRACTS SUBMITTED TO THE FLORIDA BOTULINUM TOXIN CONFERENCE NOV 1999. Movement Disorders. 16(2). 381–381. 1 indexed citations
13.
Howard, Louise, Martin Binks, A. P. Moore, & Jeremy Playfer. (2000). The Contribution of Apraxic Speech to Working Memory Deficits in Parkinson's Disease. Brain and Language. 74(2). 269–288. 13 indexed citations
14.
Smith, S J, Elizabeth Ellis, Sarah White, & A. P. Moore. (2000). A double-blind placebo-controlled study of botulinum toxin in upper limb spasticity after stroke or head injury. Clinical Rehabilitation. 14(1). 5–13. 138 indexed citations
15.
Leathley, Michael J, et al.. (1999). Reliability of the tone assessment scale and the modified ashworth scale as clinical tools for assessing poststroke spasticity. Archives of Physical Medicine and Rehabilitation. 80(9). 1013–1016. 332 indexed citations
16.
Moore, A. P., et al.. (1998). Reliability of the OSI CA 6000 Spine Motion Analyzer with a new skin fixation system when used on the thoracic spine. Manual Therapy. 3(1). 27–33. 14 indexed citations
17.
Moore, A. P. & G D Wood. (1997). Medical treatment of recurrent temporomandibular joint dislocation using botulinum toxin A. BDJ. 183(11). 415–417. 46 indexed citations
18.
Moore, A. P., et al.. (1995). The development of a new form of instrument fixation for the OSI CA 6000 spine motion analyzer. Manual Therapy. 1(1). 43–46. 10 indexed citations
19.
Moore, A. P., I A MacFarlane, & L. D. Blumhardt. (1990). Neuroleptic malignant syndrome and hypothyroidism.. Journal of Neurology Neurosurgery & Psychiatry. 53(6). 517–518. 9 indexed citations
20.
Moore, A. P., Peter O. Behan, W. Jacobson, & Wilfred L.F. Armarego. (1987). Biopterin in Parkinson's disease.. Journal of Neurology Neurosurgery & Psychiatry. 50(1). 85–87. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patricia S. Smith Breakdown of academic impact, for papers by S. Miller Breakdown of academic impact, for papers by Toshio Fukutake Breakdown of academic impact, for papers by S. Pandya Breakdown of academic impact, for papers by Jeanine Schierbecker Breakdown of academic impact, for papers by Prodip Bose Breakdown of academic impact, for papers by L. Signore Breakdown of academic impact, for papers by M. Comola Breakdown of academic impact, for papers by B. Cioni Breakdown of academic impact, for papers by Rita Krishnamurthi
Rankless by CCL
2026